Tumor-Lymph Node Mapping
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-17
SponsorUniversity of Rochester
About this trial
The purpose of this study is to assess the feasibility and safety of ICG-guided intraoperative lymphography for detecting sentinel lymph nodes (SLN) in pediatric patients with solid tumors who require retroperitoneal lymph node dissection/sampling.
This trial is a single-site cross-sectional study. The injection of ICG directly into lymphatics draining the primary tumor will take place at the time of operation after the patient is under anesthesia.
Eligibility criteria
Qualifiers
Any pediatric patient (under the age of 18 years) being treated at the University of Rochester Medical Center, Department of Surgery.
Diagnosed with pediatric solid tumor
Scheduled to undergo lymph node sampling as part of their clinical management.
Disqualifiers
Subjects with a history of iodide allergies.
Inability or unwillingness of research participant or parent/legal guardian to give written informed consent.
Currently pregnant.
Infants under 650 grams.
Trial design
Treatments tested in this trial
- ICG (Indocyanine Green)
Treatment groups
10 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov